S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY

• Aaron T. Gerds,
• Claire Harrison,
• Jean-Jacques Kiladjian,
• Ruben Mesa,
• Alessandro Vannucchi,
• Rami S. Komrokji,
• Prithviraj Bose,
• Marina Kremyanskaya,
• Adam Mead,
• Jason Gotlib,
• Fabian Sanabria,
• Niloufar Marsousi,
• Ana Carolina Giuseppi,
• Huijing Jiang,
• Jeanne Palmer,
• Kelly Mccaul,
• Vincent Ribrag,
• Srdan Verstovsek,
• Francesco Passamonti

Affiliations

Aaron T. Gerds

1 Cleveland Clinic, Cleveland, United States

Claire Harrison

2 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom

Jean-Jacques Kiladjian

3 Hôpital Saint-Louis, Paris, France

Ruben Mesa

4 Wake Forest University School of Medicine, Winston-Salem, United States

Alessandro Vannucchi

5 AOU Careggi, Florence, Italy

Rami S. Komrokji

6 Moffitt Cancer Center, Tampa, United States

Prithviraj Bose

7 University of Texas, MD Anderson Cancer Center, Houston, United States

Marina Kremyanskaya

8 Mount Sinai Hospital, New York, United States

Adam Mead

9 University of Oxford, MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

Jason Gotlib

10 Stanford Cancer Institute, Stanford, United States

Fabian Sanabria

11 Bristol Myers Squibb, Boudry, Switzerland

Niloufar Marsousi

11 Bristol Myers Squibb, Boudry, Switzerland

Ana Carolina Giuseppi

12 Bristol Myers Squibb, Princeton, United States

Huijing Jiang

12 Bristol Myers Squibb, Princeton, United States

Jeanne Palmer

13 Mayo Clinic, Phoenix, United States

Kelly Mccaul

14 University of Tennessee Medical Center, Knoxville, United States

Vincent Ribrag

15 Institut Gustave Roussy, Villejuif, France

Srdan Verstovsek

7 University of Texas, MD Anderson Cancer Center, Houston, United States

Francesco Passamonti

16 University of Insubria, Varese, Italy